Bladder cancer Board decisions

The Veteran's claim for an earlier effective date for bladder cancer was denied as the liberalizing regulations became effective on March 14, 2017.,The Veteran's claim for bilateral hearing loss is remanded and will be reconsidered.

The Veteran's service-connected disabilities did not render him unable to obtain or maintain substantially gainful employment prior to May 18, 2019.

The Veteran's bladder cancer is remanded for further development to determine if it is related to his in-service exposure, including potential herbicide agent exposure.

The Board denied service connection for prostate cancer and bladder cancer, finding that the evidence did not support a link between these conditions and active service, including exposure to ionizing radiation.

The Veteran's claim for an initial compensable rating for his service-connected bladder cancer residuals is remanded due to the need for additional medical records and a new VA examination.

The Veteran's bladder cancer has been granted presumptive service connection due to exposure to herbicides during his duty in the Republic of Vietnam. He is also receiving housebound compensation.

The Board has determined that a timely substantive appeal was not filed with respect to the December 1, 2017 statement of the case regarding service connection for prostate cancer and bladder cancer. The appeal is denied.

The Board has remanded the Veteran's claims for service connection for prostate cancer and bladder cancer due to exposure to trichloroethylene in-service. The case requires a VA examination to determine if there is at least as likely as not that the cancers are related to this exposure.

The Veteran's cause of death, bladder cancer, is presumed to be related to in-service herbicide exposure as there is no affirmative evidence to the contrary. Service connection for the cause of the Veteran's death is granted.

The Veteran's claims of service connection for kidney and bladder cancer, as well as the removal of his left kidney due to these cancers, are being remanded due to procedural issues and insufficient evidence regarding the etiology of his conditions. Further development is needed to determine if his exposure to asbestos and chemical hazards during service caused or contributed to his health problems.

The Veteran's prostate cancer is granted service connection as due to herbicide agent exposure. The claims for urothelial carcinoma, bladder cancer, prostatitis, and lung nodules are remanded for additional etiology opinions.

The Board has granted service connection for calcified granulosis, bladder cancer, and low back disability. The claim for bilateral hearing loss is remanded.

The Veteran's service-connected disabilities are deemed to be severe enough to prevent him from securing and following a substantially gainful occupation, but additional development is needed for the TDIU claim. For SMC based on need for aid and attendance, further examination is required as the Veteran has not been provided with such an evaluation.

The Board has remanded the issues of service connection for bilateral hearing loss, bladder cancer, and lower extremity neuropathy due to potential exposure to herbicide agents in Korea. The AOJ is instructed to conduct additional research into the Veteran's potential exposure.

The Board has ordered further development to determine if the Veteran was exposed to herbicide agents during his service in Korea, which could potentially establish service connection for bladder cancer.

The Board has determined that the Veteran's bladder cancer is etiologically related to his exposure to vehicle maintenance chemicals during service, and thus grants service connection for bladder cancer.

Service connection for prostate and bladder cancer is granted due to presumed exposure to herbicide agents during service.

The Veteran's initial claim for service connection of bladder cancer residuals was granted with a 40% rating from February 1, 2007 to September 3, 2014.,A 80% rating was granted for the period from September 3, 2014 to May 29, 2018. The Veteran's bladder cancer residuals caused renal dysfunction with a GFR of 15-29 mL/min/1.73 m² during this time.,The Veteran's claim for an increased rating beyond the 80% was denied from September 3, 2014 to April 5, 2022.

The Board has granted separate ratings for the Veteran's service-connected acoustic neuroma, but remanded issues related to Dupuytren's contracture of his fingers. The appeal is currently in a state where some claims are resolved and others need further development.

The Board has remanded the claims of service connection for diabetes mellitus, Type II, prostate cancer, urinary bladder cancer, and erectile dysfunction (ED) as secondary to exposure to Agent Orange due to new evidence added since the March 2020 SOC.